Showing results (241-250 of 339) with videos related to

Sort By:
Pageof 34
International Journal of Molecular Sciences|February 15, 2019
Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AMLPeter Valent, Wolfgang Kern, Gregor Hoermann, et al.
Nature Medicine|July 11, 2018
Phenotype molding of stromal cells in the lung tumor microenvironmentDiether Lambrechts, Els Wauters, Bram Boeckx, et al.
Scientific Reports|October 14, 2017
Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitisManfred Nairz, David Haschka, Stefanie Dichtl, et al.
Cancer Research|April 3, 2015
JAK Inhibition Impairs NK Cell Function in Myeloproliferative NeoplasmsKathrin Schönberg, Janna Rudolph, Maria Vonnahme, et al.
Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.
American Journal of Hematology|September 16, 2020
The prognostic value of additional copies of 1q21 in multiple myeloma depends on the primary genetic eventMaurus Locher, Michael Steurer, Emina Jukic, et al.
Genes, Chromosomes & Cancer|December 5, 2020
Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia-variantMaurus Locher, Emina Jukic, Jan-Paul Bohn, et al.
Translational Lung Cancer Research|May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysisTian Tian, Yanying Li, Juan Li, et al.
Transplantation and Cellular Therapy|May 15, 2021
Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous RecipientsAlexander Nikoloudis, Helga Wagner, Sigrid Machherndl-Spandl, et al.
Bone Marrow Transplantation|March 17, 2024
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)Jürgen Finke, Claudia Schmoor, Francis Ayuk, et al.
Pageof 34